Looking Into ENDRA Life Sciences's Recent Short Interest
Portfolio Pulse from Benzinga Insights
ENDRA Life Sciences (NYSE:NDRA) has seen a significant increase in short interest, rising 168.75% since its last report. The company now has 277 thousand shares sold short, representing 2.58% of its float. This increase in short interest could indicate bearish sentiment among investors.
June 19, 2024 | 7:00 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
ENDRA Life Sciences has experienced a 168.75% increase in short interest, now at 2.58% of its float. This could indicate bearish sentiment among investors.
The significant increase in short interest suggests that more investors are betting against the stock, which typically indicates bearish sentiment. This could lead to downward pressure on the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100